A study by Rebbeck et al. demonstrated this 90% risk reduction after bilateral prophylactic mastectomies in BRCA1/2 patients, which was a case-control study, translated into a breast cancer risk of 7% by the age of 70 years [66]. The gene discussed is BRCA1; the disease is breast carcinoma.